Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""HEMATOPOIETIC stem cell transplantation"" wg kryterium: Temat


Tytuł :
Haploidentical hematopoietic stem cell transplantation for patients with myeloid sarcoma: a single center retrospective study.
Autorzy :
Yu WJ; Peking University People's Hospital, Peking University Institute of Hematolo, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantationgy, National Clinical Research Center for Hematologic Disease, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Sun YQ; Peking University People's Hospital, Peking University Institute of Hematolo, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantationgy, National Clinical Research Center for Hematologic Disease, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Han TT; Peking University People's Hospital, Peking University Institute of Hematolo, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantationgy, National Clinical Research Center for Hematologic Disease, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Ye PP; Department of Hematology, Yinzhou Hospital Affiliated to Medical School of Ningbo University, Ningbo, China.
Zhang XH; Peking University People's Hospital, Peking University Institute of Hematolo, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantationgy, National Clinical Research Center for Hematologic Disease, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Xu LP; Peking University People's Hospital, Peking University Institute of Hematolo, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantationgy, National Clinical Research Center for Hematologic Disease, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Liu KY; Peking University People's Hospital, Peking University Institute of Hematolo, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantationgy, National Clinical Research Center for Hematologic Disease, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Yan CH; Peking University People's Hospital, Peking University Institute of Hematolo, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantationgy, National Clinical Research Center for Hematologic Disease, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Huang XJ; Peking University People's Hospital, Peking University Institute of Hematolo, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantationgy, National Clinical Research Center for Hematologic Disease, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.; Peking-Tsinghua Center for Life Sciences, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Wang Y; Peking University People's Hospital, Peking University Institute of Hematolo, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantationgy, National Clinical Research Center for Hematologic Disease, No.11, Xizhimen South Street, Xicheng District, Beijing, 100044, China. .; Collaborative Innovation Center of Hematology, Peking University, Beijing, China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Mar; Vol. 100 (3), pp. 799-808. Date of Electronic Publication: 2021 Jan 08.
Typ publikacji :
Journal Article
MeSH Terms :
Transplantation, Haploidentical*/adverse effects
Transplantation, Haploidentical*/statistics & numerical data
Hematopoietic Stem Cell Transplantation/*methods
Sarcoma, Myeloid/*therapy
Adolescent ; Adult ; Chemoprevention ; Child ; Female ; Graft vs Host Disease/epidemiology ; Graft vs Host Disease/etiology ; Graft vs Host Disease/mortality ; Graft vs Host Disease/prevention & control ; Hematopoietic Stem Cell Transplantation/adverse effects ; Hematopoietic Stem Cell Transplantation/statistics & numerical data ; Humans ; Male ; Neoplasm Recurrence, Local/epidemiology ; Retrospective Studies ; Sarcoma, Myeloid/diagnosis ; Sarcoma, Myeloid/epidemiology ; Sarcoma, Myeloid/mortality ; Siblings ; Survival Analysis ; Transplantation Conditioning/methods ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Anti-CD19 CAR-T cell therapy bridge to HSCT decreases the relapse rate and improves the long-term survival of R/R B-ALL patients: a systematic review and meta-analysis.
Autorzy :
Hu L; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Charwudzi A; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Li Q; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Zhu W; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Tao Q; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Xiong S; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China. .
Zhai Z; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 1003-1012. Date of Electronic Publication: 2021 Feb 15.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Immunotherapy, Adoptive*
Salvage Therapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Antigens, CD19/immunology ; Asian Continental Ancestry Group ; Disease-Free Survival ; Epidemiologic Studies ; European Continental Ancestry Group ; Humans ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/ethnology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Prognosis ; Recurrence ; Remission Induction ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Allogeneic hematopoietic stem cell transplantation could improve survival for pure CBF-AML patients with minimal residual disease positive after the second consolidation.
Autorzy :
Wang T; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Zhou B; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Zhang J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Zhang X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Liu T; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Qiu H; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Sun A; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Chen S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Wu D; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Xu Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Apr; Vol. 62 (4), pp. 995-998. Date of Electronic Publication: 2020 Nov 16.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
Humans ; Neoplasm, Residual ; Prognosis ; Retrospective Studies ; Transplantation, Homologous
Raport
Tytuł :
Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE.
Autorzy :
Goldschmidt H; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany. .; National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. .
Baertsch MA; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Schlenzka J; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Becker N; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
Habermehl C; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
Hielscher T; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
Raab MS; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.
Hillengass J; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Sauer S; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Müller-Tidow C; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Luntz S; Coordination Centre for Clinical Trials (KKS), University Hospital Heidelberg, Heidelberg, Germany.
Jauch A; Institute for Human Genetics, University of Heidelberg, Heidelberg, Germany.
Hose D; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Seckinger A; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Brossart P; Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, Med. Klinik und Poliklinik III, University Hospital Bonn, Bonn, Germany.
Goerner M; Department of Hematology, Oncology and Palliative Care, Community Hospital Bielefeld, Bielefeld, Germany.
Klein S; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
Schmidt-Hieber M; Clinic for Hematology and Stem Cell Transplantation, Helios-Hospital Berlin Buch, Berlin, Germany.; Clinic for Hematology and Oncology, Carl-Thiem Klinikum Cottbus, Cottbus, Germany.
Reimer P; Department of Hematology, Oncology and Stem Cell Transplantation, Evangelisches Krankenhaus Essen-Werden gGmbH, Essen, Germany.
Graeven U; Department of Hematology, Oncology and Gastroenterology, Kliniken Maria Hilf GmbH, Mönchengladbach, Germany.
Fenk R; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Duesseldorf, Germany.
Haenel M; Department of Hematology, Oncology and Stem Cell Transplantation, Klinikum Chemnitz GmbH, Chemnitz, Germany.
Martin H; Department of Hematology and Oncology, Goethe University, Frankfurt, Germany.
Lindemann HW; Department of Hematology and Oncology, Kath. Krankenhaus Hagen gem. GmbH, Hagen, Germany.
Scheid C; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
Nogai A; Internal Medicine III, Charité Campus Benjamin Franklin, Berlin, Germany.
Salwender H; Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany.
Noppeney R; Department of Hematology, University Hospital Essen, Essen, Germany.
Besemer B; Department of Hematology, Oncology and Immunology, University of Tuebingen, Tuebingen, Germany.
Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Pokaż więcej
Corporate Authors :
German Myeloma Multicenter Group (GMMG)
Źródło :
Leukemia [Leukemia] 2021 Apr; Vol. 35 (4), pp. 1134-1144. Date of Electronic Publication: 2020 Jul 21.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Multiple Myeloma/*therapy
Adolescent ; Adult ; Aged ; Animals ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biomarkers ; Biopsy ; Bone Marrow/pathology ; Chromosome Aberrations ; Combined Modality Therapy ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Mice ; Middle Aged ; Multiple Myeloma/diagnosis ; Multiple Myeloma/mortality ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Salvage Therapy ; Transplantation, Autologous ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Determinants of cardiorespiratory fitness in very long-term survivors of allogeneic hematopoietic stem cell transplantation: a national cohort study.
Autorzy :
Myrdal OH; Department of Respiratory Medicine, Oslo University Hospital, Rikshospitalet, Box 4950 Nydalen, 0424, Oslo, Norway. .; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. .
Diep PP; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pediatric Oncology and Haematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Department of Pediatric Research, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Ruud E; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pediatric Oncology and Haematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Brinch L; Department of Haematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Massey RJ; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Edvardsen E; Department of Physical Performance, The Norwegian School of Sport Sciences, Oslo, Norway.; Department of Pulmonary Medicine, Oslo University Hospital Ullevål, Oslo, Norway.
Kongerud J; Department of Respiratory Medicine, Oslo University Hospital, Rikshospitalet, Box 4950 Nydalen, 0424, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Lund MB; Department of Respiratory Medicine, Oslo University Hospital, Rikshospitalet, Box 4950 Nydalen, 0424, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Sikkeland LI; Department of Respiratory Medicine, Oslo University Hospital, Rikshospitalet, Box 4950 Nydalen, 0424, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Apr; Vol. 29 (4), pp. 1959-1967. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :
Journal Article
MeSH Terms :
Cardiorespiratory Fitness/*physiology
Hematopoietic Stem Cell Transplantation/*methods
Survivors/*statistics & numerical data
Transplantation Conditioning/*methods
Adolescent ; Adult ; Cohort Studies ; Cross-Sectional Studies ; Female ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; Male ; Middle Aged ; Survival Analysis ; Transplantation Conditioning/mortality ; Young Adult
Czasopismo naukowe
Tytuł :
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Autorzy :
Schuler E; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany. .
Wagner-Drouet EM; Department of Hematology, Oncology, Pneumology, Medical Clinic III, UCT Johannes Gutenberg-University Mainz, Mainz, Germany.
Ajib S; Department of Medicine II, Goethe University, Frankfurt am Main, Germany.
Bug G; Department of Medicine II, Goethe University, Frankfurt am Main, Germany.
Crysandt M; Department of Hematology, Oncology, Hemostasiology and Stem Cell Transplantation, Medical Clinic IV, University Hospital RWTH Aachen, Aachen, Germany.
Dressler S; Bone Marrow Transplantation Unit, Medical Clinic 5, Nürnberg, Germany.
Hausmann A; Department of Hematology, Oncology, Immunology, Palliative Care, Munich Clinic Schwabing, Munich, Germany.
Heidenreich D; Medical Clinic III, University Medicine Mannheim, Mannheim, Germany.
Hirschbühl K; Department of Hematology and Oncology, Medical Clinic II, University Hospital Augsburg, Augsburg, Germany.
Hoepting M; Medical Clinic III, University Medicine Regensburg, Regensburg, Germany.
Jost E; Department of Hematology, Oncology, Hemostasiology and Stem Cell Transplantation, Medical Clinic IV, University Hospital RWTH Aachen, Aachen, Germany.
Kaivers J; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
Klein S; Medical Clinic III, University Medicine Mannheim, Mannheim, Germany.
Koldehoff M; Clinic for Bone Marrow Transplantation, University Hospital Essen, Essen, Germany.
Kordelas L; Clinic for Bone Marrow Transplantation, University Hospital Essen, Essen, Germany.
Kriege O; Department of Hematology, Oncology, Pneumology, Medical Clinic III, UCT Johannes Gutenberg-University Mainz, Mainz, Germany.
Müller LP; Department of Internal Medicine IV, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Rautenberg C; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
Schaffrath J; Department of Internal Medicine IV, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Schmid C; Department of Hematology and Oncology, Medical Clinic II, University Hospital Augsburg, Augsburg, Germany.
Wolff D; Medical Clinic III, University Medicine Regensburg, Regensburg, Germany.
Haas R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
Bornhäuser M; Department of Internal Medicine I, University Hospital Carl Gustav Carus at the Technische Universität, Dresden, Germany.
Schroeder T; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
Pokaż więcej
Corporate Authors :
German Cooperative Transplant Study Group
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 959-968. Date of Electronic Publication: 2020 Nov 16.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Salvage Therapy*/adverse effects
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Leukemia, Myeloid, Acute/*drug therapy
Myelodysplastic Syndromes/*drug therapy
Allografts ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Azacitidine/administration & dosage ; Azacitidine/adverse effects ; Azacitidine/pharmacology ; Bridged Bicyclo Compounds, Heterocyclic/administration & dosage ; Bridged Bicyclo Compounds, Heterocyclic/adverse effects ; Combined Modality Therapy ; DNA Methylation/drug effects ; Decitabine/administration & dosage ; Decitabine/adverse effects ; Decitabine/pharmacology ; Drug Evaluation ; Febrile Neutropenia/blood ; Febrile Neutropenia/chemically induced ; Germany/epidemiology ; Humans ; Immunosuppressive Agents/adverse effects ; Immunosuppressive Agents/therapeutic use ; Kaplan-Meier Estimate ; Leukemia, Myeloid, Acute/therapy ; Leukocyte Count ; Myelodysplastic Syndromes/therapy ; Recurrence ; Retrospective Studies ; Sulfonamides/administration & dosage ; Sulfonamides/adverse effects ; Thrombocytopenia/blood ; Thrombocytopenia/chemically induced ; Transplantation Conditioning ; Tumor Lysis Syndrome/etiology
Czasopismo naukowe
Tytuł :
Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
Autorzy :
Deng DX; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wen JJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China.
Cheng YF; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Yan CH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Chen YH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Chen H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Han W; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang FR; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang JZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Qin YZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Zhao XS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. .; Collaborative Innovation Center of Hematology, Peking University, Beijing, China. .
Mo XD; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Mar 19; Vol. 21 (1), pp. 292. Date of Electronic Publication: 2021 Mar 19.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Biomarkers, Tumor/*metabolism
Leukemia, Myeloid, Acute/*therapy
Neoplasm Recurrence, Local/*epidemiology
WT1 Proteins/*metabolism
Adolescent ; Biomarkers, Tumor/analysis ; Bone Marrow/pathology ; Child ; Child, Preschool ; Disease-Free Survival ; Female ; Humans ; Incidence ; Infant ; Kaplan-Meier Estimate ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/mortality ; Leukemia, Myeloid, Acute/pathology ; Male ; Neoplasm Recurrence, Local/pathology ; Neoplasm, Residual ; Prognosis ; Risk Assessment/methods ; Transplantation, Homologous ; WT1 Proteins/analysis
Czasopismo naukowe
Tytuł :
[Bone marrow transplantation patients in the intensive care unit].
Autorzy :
Stecher SS; Medizinische Klinik und Poliklinik II, Gastroenterologie & Hepatologie, Klinikum der Ludwig-Maximilians-Universität München, München, Deutschland.
Stemmler HJ; Medizinische Klinik und Poliklinik III, Hämatologie und Onkologie, Klinikum der Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, München, Deutschland. .
Tischer J; Medizinische Klinik und Poliklinik III, Hämatologie und Onkologie, Klinikum der Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, München, Deutschland.
von Bergwelt-Baildon M; Medizinische Klinik und Poliklinik III, Hämatologie und Onkologie, Klinikum der Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, München, Deutschland.
Liebregts T; Innere Medizin V: Hämatologie, Onkologie und Rheumatologie, Universität Heidelberg, Heidelberg, Deutschland.
Fraccaroli A; Medizinische Klinik und Poliklinik III, Hämatologie und Onkologie, Klinikum der Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, München, Deutschland.
Pokaż więcej
Transliterated Title :
Der knochenmarktransplantierte Patient auf der Intensivstation.
Źródło :
Medizinische Klinik, Intensivmedizin und Notfallmedizin [Med Klin Intensivmed Notfmed] 2021 Mar; Vol. 116 (2), pp. 111-120. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Bone Marrow Transplantation*
Hematopoietic Stem Cell Transplantation*
Critical Care ; Humans ; Intensive Care Units ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
Autorzy :
Kołodziejczak M; Department of Anesthesiology and Intensive Care, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University Torun, Antoni Jurasz University Hospital No.1, Bydgoszcz, Poland.
Gil L; Department of Hematology and Hematopoietic Cell Transplantation, Medical University, Poznan, Poland.
de la Camara R; Department of Hematology, Hospital de la Princesa, Madrid, Spain.
Styczyński J; Department of Pediatric Hematology and Oncology, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University Torun, Antoni Jurasz University Hospital No.1, ul. Sklodowskiej-Curie 9, 85-094, Bydgoszcz, Poland. .
Pokaż więcej
Corporate Authors :
Infectious Diseases Working Party, European Society for Blood and Marrow Transplantation
Źródło :
Annals of hematology [Ann Hematol] 2021 Mar; Vol. 100 (3), pp. 763-777. Date of Electronic Publication: 2021 Jan 25.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/mortality
Hematopoietic Stem Cell Transplantation*/statistics & numerical data
Epstein-Barr Virus Infections/*epidemiology
Hematologic Neoplasms/*epidemiology
Hematologic Neoplasms/*therapy
Tissue Donors/*statistics & numerical data
Transplant Recipients/*statistics & numerical data
Adolescent ; Adult ; Aged ; Epstein-Barr Virus Infections/complications ; Epstein-Barr Virus Infections/diagnosis ; Female ; Graft vs Host Disease/diagnosis ; Graft vs Host Disease/etiology ; Graft vs Host Disease/mortality ; Hematologic Neoplasms/complications ; Hematologic Neoplasms/diagnosis ; Herpesvirus 4, Human/physiology ; Humans ; Male ; Middle Aged ; Prognosis ; Recurrence ; Seroepidemiologic Studies ; Survival Analysis ; Transplantation, Homologous/adverse effects ; Transplantation, Homologous/mortality ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
[Lung transplantation in a child with idiopathic pneumonia syndrome after hematopoietic stem cell transplantation].
Autorzy :
Qian J; Pediatric Critical Care Unit, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Zhang J; Pediatric Critical Care Unit, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Ning BT; Pediatric Critical Care Unit, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Zhang F; Pediatric Critical Care Unit, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Luo CY; Department of Hematology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Wang JM; Department of Hematology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Yin MZ; Department of Pathology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Pokaż więcej
Źródło :
Zhonghua er ke za zhi = Chinese journal of pediatrics [Zhonghua Er Ke Za Zhi] 2021 May 02; Vol. 59 (5), pp. 412-414.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*/adverse effects
Lung Transplantation*
Pneumonia*/etiology
Child ; Humans
Czasopismo naukowe
Tytuł :
[The effect of donor cytomegalovirus serological status on the outcome of allogeneic stem cell transplantation].
Autorzy :
Liu J; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Fu Q; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Wang Y; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Wang FR; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Han W; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Ma YR; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Yan CH; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Han TT; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Wang JZ; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Wang ZD; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Zhang XH; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Xu LP; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Liu KY; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Huang XJ; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Sun YQ; Department of Hematology, Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Pokaż więcej
Źródło :
Zhonghua nei ke za zhi [Zhonghua Nei Ke Za Zhi] 2021 May 01; Vol. 60 (5), pp. 459-465.
Typ publikacji :
Journal Article
MeSH Terms :
Cytomegalovirus Infections*/epidemiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Cytomegalovirus ; Humans ; Neoplasm Recurrence, Local ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Hemorrhagic cystitis from BK virus in a patient with AIDS.
Autorzy :
Hassold N; Infectious and Tropical Diseases Service.
Baltes V; Infectious and Tropical Diseases Service.
Martin A; Laboratory of Anatomopathology, Hôpital Avicenne, Bobigny, France.
Méchaï F; Infectious and Tropical Diseases Service.
Bouchaud O; Infectious and Tropical Diseases Service.
Cordel H; Infectious and Tropical Diseases Service.
Pokaż więcej
Źródło :
AIDS (London, England) [AIDS] 2021 May 01; Vol. 35 (6), pp. 999-1001.
Typ publikacji :
Journal Article
MeSH Terms :
Acquired Immunodeficiency Syndrome*/complications
BK Virus*
Cystitis*/complications
HIV Infections*/complications
Hematopoietic Stem Cell Transplantation*
Polyomavirus Infections*/complications
Humans
Czasopismo naukowe
Tytuł :
Haploidentical hematopoietic cell transplantation is even more advantageous during the COVID-19 pandemic.
Autorzy :
Stanley K; Department of Pediatrics, University of Arizona, Tucson, AZ, USA.; Banner University Medical Center, Tucson, AZ, USA.
Hanmod S; Department of Pediatrics, University of Arizona, Tucson, AZ, USA.; Banner Children's at Desert, Mesa, AZ, USA.
Simpson RJ; Department of Pediatrics, University of Arizona, Tucson, AZ, USA.; Department of Nutritional Sciences, University of Arizona, Tucson, AZ, USA.; The University of Arizona Cancer Center, Tucson, AZ, USA.; Department of Immunobiology, University of Arizona, Tucson, AZ, USA.
Katsanis E; Department of Pediatrics, University of Arizona, Tucson, AZ, USA.; Banner University Medical Center, Tucson, AZ, USA.; Banner Children's at Desert, Mesa, AZ, USA.; The University of Arizona Cancer Center, Tucson, AZ, USA.; Department of Immunobiology, University of Arizona, Tucson, AZ, USA.; Department of Medicine, University of Arizona, Tucson, AZ, USA.; Department of Pathology, University of Arizona, Tucson, AZ, USA.
Pokaż więcej
Źródło :
Pediatric transplantation [Pediatr Transplant] 2021 May; Vol. 25 (3), pp. e14004. Date of Electronic Publication: 2021 Mar 17.
Typ publikacji :
Letter; Comment
MeSH Terms :
COVID-19*
Hematopoietic Stem Cell Transplantation*
Cohort Studies ; Humans ; Pandemics ; SARS-CoV-2 ; Transplantation Conditioning
Opinia redakcyjna
Tytuł :
Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation.
Autorzy :
Liu J; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Zhang XH; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Xu LP; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Wang Y; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Yan CH; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Chen H; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Chen YH; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Han W; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Wang FR; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Wang JZ; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Cheng YF; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Qin YZ; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Liu KY; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Huang XJ; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.; Peking-Tsinghua Center for Life Sciences, Beijing, 100044, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Zhao XS; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China. .; Collaborative Innovation Center of Hematology, Peking University, Beijing, China. .
Mo XD; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China. .; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 May; Vol. 100 (5), pp. 1267-1281. Date of Electronic Publication: 2021 Mar 13.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Histone-Lysine N-Methyltransferase/*genetics
Leukemia, Myeloid, Acute/*diagnosis
Myeloid-Lymphoid Leukemia Protein/*genetics
Neoplasm, Residual/*diagnosis
Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Gene Rearrangement ; Humans ; Immunotherapy ; Infant ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/therapy ; Male ; Middle Aged ; Neoplasm, Residual/genetics ; Neoplasm, Residual/therapy ; Prognosis ; Transplantation, Homologous ; Young Adult
Czasopismo naukowe
Tytuł :
HIV-1LAI Nef blocks the development of hematopoietic stem/progenitor cells into T lymphoid cells.
Autorzy :
Zou W; Department of Infectious Diseases.
Xing J; Department of Burn.
Wang F; Department of Gynecology and Obstetrics.
Chen X; Department of Gynecology and Obstetrics.
Liu Q; Department of Gynecology and Obstetrics.
Wang J; Department of Infectious Diseases.
Zou S; Department of Infectious Diseases.
Chen L; Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University.
Fu X; Jiangxi Provincial Key Laboratory of Preventive Medicine, School of Public Health.
Zhou Z; Department of Clinical Medicine, Nanchang University, Nanchang, Jiangxi, China.
Wan Z; Department of Clinical Medicine, Nanchang University, Nanchang, Jiangxi, China.
Pokaż więcej
Źródło :
AIDS (London, England) [AIDS] 2021 May 01; Vol. 35 (6), pp. 851-860.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Infections*
HIV-1*
Hematopoietic Stem Cell Transplantation*
Animals ; CD4-Positive T-Lymphocytes ; Mice ; nef Gene Products, Human Immunodeficiency Virus
Czasopismo naukowe
Tytuł :
Robust and sustained antibody response to SARS-CoV-2 in a child pre and post autologous hematopoietic stem cell transplant.
Autorzy :
Gupta AK; Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Ramachandran M; Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Meena JP; Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Dwivedi T; Department of Laboratory Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India.
Singh U; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Gupta R; Department of Laboratory Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India.
Seth R; Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Pokaż więcej
Źródło :
Pediatric blood & cancer [Pediatr Blood Cancer] 2021 May; Vol. 68 (5), pp. e28848. Date of Electronic Publication: 2020 Dec 22.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Antibodies, Viral/*blood
Immunocompromised Host/*immunology
SARS-CoV-2/*immunology
Antineoplastic Agents/therapeutic use ; COVID-19 ; Child, Preschool ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Irinotecan/therapeutic use ; Male ; Neuroblastoma/drug therapy ; Temozolomide/therapeutic use ; Transplantation, Autologous
Raport
Tytuł :
B regulatory cells and monocyte subpopulations in patients with chronic graft-vs-host disease.
Autorzy :
Babić A; Antonija Babić, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Kišpatićeva 12, 10000 Zagreb, .
Kurić L
Zelić Kerep A
Desnica L
Lelas A
Milošević M
Serventi-Seiwerth R
Duraković N
Peric Z
Mravak Stipetić M
Bilic E
Čeović R
Barešić M
Vukić T
Ljubas Kelečić D
Mazić S
Bojanić I
Hećimović A
Bilic E
Zadro R
Vrhovac R
Pavletic SZ
Batinić D
Pulanić D
Pokaż więcej
Źródło :
Croatian medical journal [Croat Med J] 2021 Apr 30; Vol. 62 (2), pp. 154-164.
Typ publikacji :
Journal Article
MeSH Terms :
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Adult ; Aged ; Chronic Disease ; Female ; Humans ; Male ; Middle Aged ; Monocytes ; Prospective Studies ; United States ; Young Adult
Czasopismo naukowe
Tytuł :
[Biomechanical study of polymethyl methacrylate bone cement and allogeneic bone for strengthening sheep vertebrae].
Autorzy :
Wang Z; Department of Orthopedics, SSL Central Hospital of Dongguan City, Affiliated Shilong People's Hospital of Southern Medical University, Dongguan Guangdong, 523326, P.R.China.
Zhang X; Department of Orthopedics, SSL Central Hospital of Dongguan City, Affiliated Shilong People's Hospital of Southern Medical University, Dongguan Guangdong, 523326, P.R.China.
Li Z; Department of Orthopedics, SSL Central Hospital of Dongguan City, Affiliated Shilong People's Hospital of Southern Medical University, Dongguan Guangdong, 523326, P.R.China.
Feng Q; Department of Orthopedics, SSL Central Hospital of Dongguan City, Affiliated Shilong People's Hospital of Southern Medical University, Dongguan Guangdong, 523326, P.R.China.
Chen J; Department of Spinal Surgery, Nanfang Hospital, Southern Medical University, Guangzhou Guangdong, 510010, P.R.China.
Xie W; Department of Orthopedics, SSL Central Hospital of Dongguan City, Affiliated Shilong People's Hospital of Southern Medical University, Dongguan Guangdong, 523326, P.R.China.
Pokaż więcej
Źródło :
Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery [Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi] 2021 Apr 15; Vol. 35 (4), pp. 471-476.
Typ publikacji :
Journal Article
MeSH Terms :
Fractures, Compression*/surgery
Hematopoietic Stem Cell Transplantation*
Spinal Fractures*
Vertebroplasty*
Animals ; Biomechanical Phenomena ; Bone Cements ; Lumbar Vertebrae/injuries ; Polymethyl Methacrylate ; Sheep
Czasopismo naukowe
Tytuł :
Sitagliptin for Prophylaxis of Acute Graft-versus-Host Disease.
Autorzy :
Jaschke NP; Technische Universität Dresden, Dresden, Germany .
Link-Rachner CS; Technische Universität Dresden, Dresden, Germany .
Rachner TD; Technische Universität Dresden, Dresden, Germany .
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Apr 08; Vol. 384 (14), pp. 1375.
Typ publikacji :
Letter; Comment
MeSH Terms :
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Dipeptidyl Peptidase 4 ; Humans ; Sitagliptin Phosphate/therapeutic use ; Transplantation Conditioning
Opinia redakcyjna
Tytuł :
Sitagliptin for Prophylaxis of Acute Graft-versus-Host Disease.
Autorzy :
Cooper DL; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ .
Strair R; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ .
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Apr 08; Vol. 384 (14), pp. 1374-1375.
Typ publikacji :
Letter; Comment
MeSH Terms :
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Dipeptidyl Peptidase 4 ; Humans ; Sitagliptin Phosphate/therapeutic use ; Transplantation Conditioning
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies